With 0.59 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.98 million shares. The 52-week range on CRNT shows that it touched its highest point at $5.73 and its lowest point at $1.95 during that stretch. It currently has a 1-year price target of $6.12. Beta for the stock currently stands at 1.05.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of CRNT was up-trending over the past week, with a rise of 0.84%, but this was up by 1.69% over a month. Three-month performance dropped to -10.11% while six-month performance fell -41.03%. The stock lost -8.05% in the past year, while it has lost -48.61% so far this year. A look at the trailing 12-month EPS for CRNT yields 0.26 with Next year EPS estimates of 0.41. For the next quarter, that number is 0.03. This implies an EPS growth rate of -31.71% for this year and 44.64% for next year.
Float and Shares Shorts:
At present, 88.39 million CRNT shares are outstanding with a float of 65.72 million shares on hand for trading.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for CRNT since 1 analysts follow the stock currently. There are 1 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $0.42953 being high and $0.32476 being low. For CRNT, this leads to a yearly average estimate of $0.36667.
